Objectives: This study examined the rate of Gleason pattern 5 and the influence of tertiary Gleason pattern 5 on oncological outcomes. Methods: Four hundred sixty-six patients underwent a radical prostatectomy between 1993 and 2008. Each surgical specimen was reviewed and assessed for the tumor diameter, Gleason score (which was based on the 2005 International Society of Urological Pathology Consensus Conference criteria) and the percentage of Gleason pattern 5. Results: The median patient age was 68.0 years old and the median prostate-specific antigen level was 9.28 ng/ml. A tertiary Gleason pattern 5 was present in 24.2% of patients with a Gleason score of ,9; in 12.2% of patients with a Gleason score of 3 þ 4 and in 45.9% of patients with a Gleason score of 4 þ 3. A multivariate analysis showed that a tertiary Gleason pattern 5 was not independently associated with biochemical recurrence-free survival among patients in the Gleason score of 7 and 8 pN0 groups. One hundred eighty-seven patients had any rate of Gleason pattern 5 and significantly worse pathological factors, compared with patients who did not have this pattern. A multivariate analysis of all patients showed that the surgical margin, Gleason score, prostate-specific antigen level and pathological stage were all independent predictors of biochemical recurrence. However, the rate of Gleason pattern 5 was not an independent factor. Conclusions: Tertiary Gleason pattern 5 was not a significant predictive factor for biochemical recurrence. The rate of Gleason pattern 5 was associated with adverse pathological factors.
INTRODUCTION
A radical prostatectomy is a major treatment option for localized prostate cancer. The oncological goal of a radical prostatectomy for a clinically localized prostate cancer is the complete resection of the prostate-in other words, a negative surgical margin (NSM). However, despite recent advances in surgical methods, recent series demonstrate that a biochemical recurrence occurs in 15 -44% of patients after a radical prostatectomy (1 -5) . Many investigators have reported predictive factors for biochemical recurrence such as prostate-specific antigen (PSA), pathological stage, the Gleason score and surgical margin (1 -4,6) . The Gleason score especially is reportedly an important predictive factor for biochemical recurrence and for cancer-specific survival (6 -9) . However, in 2005 the International Society of Urological Pathology (ISUP) Consensus Conference reviewed and changed the Gleason scoring (10) . A consensus was achieved on categorizing the various types of Gleason patterns, with the exception of one part. Although prostate cancer often presents with more than two types of Gleason patterns, the ISUP Consensus Conference moreover addressed the tertiary pattern. The most frequent pattern and the highest level of malignancy are determined from the biopsy specimen. However, a surgical specimen may show many patterns that are combined to calculate the Gleason score. In surgical specimens, the tertiary pattern 5 is therefore not reflected in the Gleason score. The concept of a tertiary Gleason pattern remains an important issue in the urology field, and recent studies suggest that the tertiary pattern is significant (11 -14) . This study examined the association between the rate of Gleason pattern 5, especially tertiary Gleason pattern 5 and the oncological outcomes of patients.
PATIENTS AND METHODS
Five hundred sixty-three radical prostatectomies were performed from 1993 through 2008 at the National Hospital Organization Shikoku Cancer Center. All patients underwent an open retropubic approach, except for three patients who were treated using a perineal approach. The indications for radical prostatectomy were patients who had a clinically localized prostate cancer and who were 75 years of age or younger. Clinical stage T3 was also an indication for surgery, but the Gleason score and the PSA level were carefully assessed and explained to the patients. Using Walsh's technique, two staff urologists or staff under their supervision performed retropubic radical prostatectomies. The physician performed a nerve-sparing technique if a patient wanted to preserve sexual function. When prioritizing cancer control, the indications for a nerve-sparing procedure depended on the pre-operative factors (e.g. the number and Gleason score of the positive biopsy cores, the PSA level or patient preference) and intra-operative factors.
After the late 1990s, androgen deprivation therapy (ADT) was not used in either the neoadjuvant or adjuvant setting. Patients were excluded from the present study if they had received neoadjuvant ADT in the early 1990s (73 patients) or had received surgical castration at the same time as the radical prostatectomy (15 patients). Patients with pathological stage T0 (3 patients) or no pathological material (6 patients) were also excluded. Four hundred sixty-six patients were finally evaluated in this study. These patients did not receive any adjuvant therapy (i.e. ADT and radiotherapy) unless there was a biochemical recurrence.
Pathological examinations were performed using the whole-mount step-section technique. The specimens were fixed, and the distal and proximal parts of the prostate were amputated. These tissues were sectioned in the sagittal plane, and the remainder of the prostate was cut serially at 5 mm intervals. A single pathologist (N.T.) reviewed all hematoxylin and eosin pathological slides of the radical prostatectomy specimens. The Gleason score, tumor diameter and the surgical margin status were assessed in each surgical specimen. In 2008, each patient's Gleason score was reviewed (in accordance with the 2005 ISUP Consensus Conference criteria) (10) . Gleason pattern 5 for each tumor was calculated from the occupation ratio. The occupation ratio in patients with a second tumor was calculated by combining the main tumor and the second tumor. The pathological stage was determined by using the 2002 TNM classification. The tumor diameter was determined by marking both ends of the tumor with a pen and measuring this distance directly with a ruler on a glass slide (15) . A positive surgical margin (PSM) was defined as the presence of any tumor cells at the margin of the resection. The presence of seminal vesicle involvement and nodal involvement were also assessed. If multiple tumors were present in one patient, the largest and second largest tumors were assessed. The Gleason score of the main tumor and worse pathological findings were used to evaluate in multiple tumors. No other tumors were analyzed if there were no specific findings from patients with multiple tumors.
All patients were evaluated at 1 -3 month intervals for 5 years after surgery, and then bi-annually; the examination included a PSA measurement and digital rectal examination. A biochemical recurrence was defined as a PSA level .0.2 ng/ml. A patient was considered to have a biochemical recurrence on the day of surgery if the patient's PSA level had never been ,0.1 ng/ml. Imaging studies (including CT, MRI and radioisotope bone scans) were indicated only after a biochemical recurrence or clinical disease progression.
The chi-square test was used to evaluate the relationship among the various clinical and pathological parameters. The biochemical recurrence-free survival of the patients was compared by using the Kaplan -Meier method and analyzed by the log-lank test. The Cox proportional hazards models were used to assess the risk of biochemical recurrence. Pathological stage (pT2 vs. pT3), surgical margin (positive vs. negative), nerve sparing (yes vs. no) and year of surgery (annually) were modeled as categorical variables. Tumor length, rate of Gleason pattern 5, PSA, age and Gleason score were modeled as continuous variables. The level of statistical significance was P , 0.05 in all analyses. The SPSS software package ver. 17.0J (SPSS Japan, Inc., Tokyo, Japan) was used for all statistical analyses.
RESULTS
The median patient age was 68.0 years old, the median PSA level was 9.28 ng/ml and the median follow-up period was 53.7 months. The median primary tumor diameter was 1.8 cm. Multiple tumors were found in 341 patients and the median secondary tumor diameter was 0.5 cm. Forty-three patients had a Gleason score of ,7; 267 patients had a Gleason score of 7; 58 patients had a Gleason score of 8 and 98 patients had a Gleason score .8 (Table 1) .
Tertiary Gleason pattern 5 was present in 24.2% of all patients with a Gleason score of ,9. A tertiary Gleason Table 2 ). The 5-and 10 year biochemical recurrence-free survival rates were better in patients with a low Gleason score than in patients with a high Gleason score (Fig. 1) (Fig. 2) . A multivariate analysis showed that a tertiary Gleason pattern 5 was not an independent factor for biochemical recurrence-free survival in patients in the Gleason score 7 and 8 pN0 groups. The surgical margin and the PSA level were independent predictors of biochemical recurrence in patients in the Gleason score 7 and pN0 groups. In the Gleason 7 group, patients with a Gleason score of 3 þ 4 or 4 þ 3 had the same results; the tertiary Gleason pattern 5 was not an independent predictive factor in either subgroup. The independent predictors of biochemical recurrence were the same in the Gleason score 7 and 8 groups (Table 3) .
One hundred seventy of the 466 primary tumors and 34 of 341 secondary tumors were found to have any rate of Gleason pattern 5. One hundred eighty-seven patients had Gleason pattern 5 in their primary and/or secondary tumors, while 279 patients did not. A Gleason pattern 5 was present in ,5% of the cancer area in 36 patients; in 5 -25% of the cancer area in 101 patients; in 25 -50% of the cancer area in 40 patients and in .50% of the cancer area in 10 patients ( Table 4 ). The tumor diameter and the PSA level were significantly greater in the Gleason pattern 5 group patients than in patients without this pattern. As expected, the Gleason score, a PSM and the rate of pN1 were higher in patients with Gleason pattern 5 than in patients without this pattern. In the pT3 group, patients with seminal vesicle invasion had more Gleason pattern 5 (Table 5) .
A multivariate analysis showed that the surgical margin, the Gleason score, the PSA level and the pathological stage were all independent predictors of biochemical recurrence in all patients. However, the rate of Gleason pattern 5 was not an independent predictive factor. The rate of Gleason pattern 5 in addition was not an independent factor among the pT2 and pT3pN0 groups. The surgical margin, PSA and year of surgery were independent predictors of biochemical recurrence in the pT2pN0 group. The surgical margin, the Gleason score and age were independent predictors of biochemical recurrence in the pT3pN0 group. The Gleason score and the pathological stage were independent factors in the NSM group, but the presence of a Gleason pattern 5 was not a significant factor. 
DISCUSSION
There are many prognostic factors such as the surgical margin, the pathological stage and PSA level that predict biochemical recurrence after a radical prostatectomy (1 -4,6 ). The Gleason score, unlike other factors, is associated with both biochemical recurrence and cancer-specific survival (6 -9). Freedland et al. (6) report that the Gleason score, the PSA doubling time and the time from surgery to biochemical recurrence are all significant risk factors for the time to prostate-specific mortality. However, only the Gleason score was a pathological factor. In 2005, the role of the Gleason score as a prognostic factor was largely revised (10). A consensus was achieved concerning the categorization of the various types of Gleason patterns, with the exception of a part. The handling of the tertiary pattern was moreover determined, although prostate cancer often presents with more than two types of Gleason patterns. The most frequent pattern and the highest level of malignancy are determined from the biopsy specimen. However, a surgical specimen may show many patterns that are combined to calculate the Gleason score. Therefore, the Gleason score does not reflect the tertiary pattern 5. Recent studies suggest that the tertiary pattern is significant. A tertiary pattern is observed in 7.5 -48% of specimens and it is associated with biochemical recurrence (11) (12) (13) (14) . This study examined whether tertiary Gleason pattern 5 (which was present in 24.2% of the patients in the current series) was correlated with biochemical recurrence. Tertiary Gleason pattern 5 was not a significant factor for biochemical recurrence in the Gleason score 7 and 8 subgroups. However, patients in the Gleason score 8 subgroup with tertiary Gleason pattern 5 tended to have a poorer survival. Tertiary Gleason pattern 5 may become important factor for biochemical recurrence if the observation period is prolonged in the future.
In specimens with a Gleason score of 7, some investigators report that the presence of a tertiary Gleason pattern 5 is significant (16 -19) . Whittemore et al. (19) report that a tertiary Gleason pattern 5 in patients with a Gleason score of 7 is associated with aggressive pathological features and biochemical recurrence-free survival. Other investigators report similar results. However, the current results differ and the significant factors in patients with a Gleason score of 7 were the surgical margin and the PSA level. In the current series, the biochemical recurrence-free survival in patients with a tertiary Gleason pattern 5 tended to be worse during first 5 years after surgery, compared with patients in the Gleason score 7 subgroup with no tertiary pattern. Therefore, a significant difference may appear during an extended observation period. By contrast, patients with a Gleason score of 4 þ 3 had poorer biochemical-free survival, compared with patients having a Gleason score of 3 þ 4. Therefore, we examined the significance of the presence of a tertiary Gleason pattern 5 in patients with a Gleason score of 7 who were divided into 3 þ 4 and 4 þ 3 subgroups. However, the tertiary Gleason pattern 5 was determined not to be a meaningful factor. This study also examined whether the rate of Gleason pattern 5 in all patients was correlated with biochemical recurrence. Cheng et al. (7) report that the combined percentage of Gleason patterns 4 and 5 was a powerful predictor of prostate cancer-specific survival. The Gleason score was correlated with biochemical failure; however, there was no correlation between the Gleason score and the rate of Gleason pattern 5. The results were the same for the NSM, pT2 and pT3 groups. However, the presence of a Gleason pattern 5 was significantly associated with pathological factors. The surgical margin was recognized as the most important and strongest prognostic factor in this study. It is therefore important to achieve an NSM.
Successfully avoiding PSMs requires an understanding of the anatomy around the prostate (20 -22) . Poor visualization due to uncontrolled bleeding or insufficient mobilization of the distal portion of the prostate may lead to an inappropriate excision line into the apex. The locations of the apex and urethra are completely evident, and the dorsal venous complex must be carefully dissected. Further improvements in surgical techniques would help decrease the possibility of having a PSM and recurrence. In our experience during the early 1990s, it was difficult to distinguish the anatomical features around the prostate, and the incidence of PSM was therefore high. The incidence of PSMs has since slowly decreased because of better recognition of the anatomy around the prostate and technical progresses in surgery. One surgeon (K.H.) in the current series found PSMs in only 18% of patients who recently underwent operations. However, there may be some stage-related bias due to tumor migration over the years (data not shown).
There were some limitations with this study. First, this was a retrospective study with a duration of about 16 years. Stage migration occurred during this period because of widespread PSA screening. Therefore, the tumors resected during the first years may have differed from those resected later. Second, the follow-up period was relatively short; therefore, only biochemical recurrence was examined. Only five patients died from prostate cancer during the observation period in this study. Future studies are thus required that examine cancer-specific survival rather than biochemical recurrence. 
